Ototoxic Effect of Erythromycin Therapy
- 1 April 1984
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 110 (4) , 258-260
- https://doi.org/10.1001/archotol.1984.00800300050011
Abstract
• Thirty-two cases of sudden, symmetrical, high-frequency, sensorineural hearing loss associated with intravenous (IV) and oral erythromycin therapy have been published since 1973. We treated a patient with reversible ototoxicity associated with IV erythromycin for the treatment of legionnaire's disease. (Arch Otolaryngol 1984;110:258-260)Keywords
This publication has 7 references indexed in Scilit:
- Ototoxicity of Erythromycin in Patients with Renal InsufficiencyNew England Journal of Medicine, 1979
- Ototoxicity of erythromycin lactobionateActa Clinica Belgica, 1979
- Reversible Sensorineural Hearing Loss with Intravenous Erythromycin LactobionateAnnals of Otology, Rhinology & Laryngology, 1977
- Drug OtotoxicityPublished by Springer Nature ,1976
- Partial Deafness after ErythromycinNew England Journal of Medicine, 1975
- Transient Perceptive Deafness due to Erythromycin LactobionatePublished by American Medical Association (AMA) ,1973
- Inner ear concentrations and ototoxicity of different antibiotics in local and systemic applicationInternational Journal of Audiology, 1973